These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Sirol M; Fuster V; Badimon JJ; Fallon JT; Moreno PR; Toussaint JF; Fayad ZA Circulation; 2005 Sep; 112(11):1594-600. PubMed ID: 16145001 [TBL] [Abstract][Full Text] [Related]
8. Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. Neubauer AM; Caruthers SD; Hockett FD; Cyrus T; Robertson JD; Allen JS; Williams TD; Fuhrhop RW; Lanza GM; Wickline SA J Cardiovasc Magn Reson; 2007; 9(3):565-73. PubMed ID: 17365236 [TBL] [Abstract][Full Text] [Related]
9. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Yuan C; Beach KW; Smith LH; Hatsukami TS Circulation; 1998 Dec; 98(24):2666-71. PubMed ID: 9851951 [TBL] [Abstract][Full Text] [Related]
10. Improved molecular imaging contrast agent for detection of human thrombus. Winter PM; Caruthers SD; Yu X; Song SK; Chen J; Miller B; Bulte JW; Robertson JD; Gaffney PJ; Wickline SA; Lanza GM Magn Reson Med; 2003 Aug; 50(2):411-6. PubMed ID: 12876719 [TBL] [Abstract][Full Text] [Related]
11. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. Frias JC; Williams KJ; Fisher EA; Fayad ZA J Am Chem Soc; 2004 Dec; 126(50):16316-7. PubMed ID: 15600321 [TBL] [Abstract][Full Text] [Related]
12. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Winter PM; Morawski AM; Caruthers SD; Fuhrhop RW; Zhang H; Williams TA; Allen JS; Lacy EK; Robertson JD; Lanza GM; Wickline SA Circulation; 2003 Nov; 108(18):2270-4. PubMed ID: 14557370 [TBL] [Abstract][Full Text] [Related]
13. Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging. Neubauer AM; Myerson J; Caruthers SD; Hockett FD; Winter PM; Chen J; Gaffney PJ; Robertson JD; Lanza GM; Wickline SA Magn Reson Med; 2008 Nov; 60(5):1066-72. PubMed ID: 18956457 [TBL] [Abstract][Full Text] [Related]
15. Gadofosveset-enhanced magnetic resonance imaging of human carotid atherosclerotic plaques: a proof-of-concept study. Lobbes MB; Heeneman S; Passos VL; Welten R; Kwee RM; van der Geest RJ; Wiethoff AJ; Caravan P; Misselwitz B; Daemen MJ; van Engelshoven JM; Leiner T; Kooi ME Invest Radiol; 2010 May; 45(5):275-81. PubMed ID: 20351652 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of atherosclerotic carotid plaque composition with magnetic resonance imaging using different sequences]. Wang Y; Wang QJ; Cai YQ; Ma L; Cai JM Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):299-303. PubMed ID: 21354916 [TBL] [Abstract][Full Text] [Related]
17. Quantification of water exchange kinetics for targeted PARACEST perfluorocarbon nanoparticles. Cai K; Kiefer GE; Caruthers SD; Wickline SA; Lanza GM; Winter PM NMR Biomed; 2012 Feb; 25(2):279-85. PubMed ID: 21751273 [TBL] [Abstract][Full Text] [Related]
18. Assessment of human atherosclerotic carotid plaque components with multisequence MR imaging: initial experience. Cappendijk VC; Cleutjens KB; Kessels AG; Heeneman S; Schurink GW; Welten RJ; Mess WH; Daemen MJ; van Engelshoven JM; Kooi ME Radiology; 2005 Feb; 234(2):487-92. PubMed ID: 15671004 [TBL] [Abstract][Full Text] [Related]
19. Perfusion-weighted magnetic resonance imaging in patients with carotid artery disease before and after carotid endarterectomy. Doerfler A; Eckstein HH; Eichbaum M; Heiland S; Benner T; Allenberg JR; Forsting M J Vasc Surg; 2001 Oct; 34(4):587-93. PubMed ID: 11668309 [TBL] [Abstract][Full Text] [Related]
20. Noise and motion correction in dynamic contrast-enhanced MRI for analysis of atherosclerotic lesions. Kerwin WS; Cai J; Yuan C Magn Reson Med; 2002 Jun; 47(6):1211-7. PubMed ID: 12111968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]